Health
Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone – Science Codex
Bottom Line: Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival.
Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research
Author: David A. Reardon, MD, clinical director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute in Boston
Background: “Dexamethasone is a potent…
Continue Reading
-
Noosa News22 hours agoMan dies after stabbing in inner-city unit
-
Noosa News18 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
General12 hours agoAlbo and Dutton do battle for the Port of Darwin
-
General24 hours agoCheap batteries pledge powers Labor re-election push